CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- DEF 14A Proxy Proxy Statement
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K/A Event Results of operations
- 8-K Event Results of operations
- 4 Grant or award Director acquired 15,902 shares (grant or award)
- 4 Grant or award Director acquired 14,728 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 15,680 shares (grant or award)
- 4 Grant or award Director acquired 16,442 shares (grant or award)
- 4 Grant or award Director acquired 4,031 shares (grant or award)
- 4 Grant or award Director acquired 9,205 shares (grant or award)
- 8-K/A Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 8-K Event Bylaws or fiscal year change
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
Page 22 of 78 · 1,549 filings